Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
about
Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaTreatment of erythrocytes with the 2-cys peroxiredoxin inhibitor, Conoidin A, prevents the growth of Plasmodium falciparum and enhances parasite sensitivity to chloroquineActivity of Herbal Medicines on Plasmodium falciparum Gametocytes: Implications for Malaria Transmission in GhanaMacrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum.Initiation of gametocytogenesis at very low parasite density in Plasmodium falciparum infection.Bioluminescence Method for In Vitro Screening of Plasmodium Transmission-Blocking Compounds.High yield purification of Plasmodium falciparum merozoites for use in opsonizing antibody assays.Efficacy of intranasal administration of artesunate in experimental cerebral malariaThe Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites.New Assays to Characterise Growth-Related Phenotypes of Plasmodium falciparum Reveal Variation in Density-Dependent Growth Inhibition between Parasite Lines.Plasmodium parasites mount an arrest response to dihydroartemisinin, as revealed by whole transcriptome shotgun sequencing (RNA-seq) and microarray study.A portable image-based cytometer for rapid malaria detection and quantification.Quantitative phospho-proteomics reveals the Plasmodium merozoite triggers pre-invasion host kinase modification of the red cell cytoskeleton.Spirocyclic chromanes exhibit antiplasmodial activities and inhibit all intraerythrocytic life cycle stages.Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum.Sequential processing of merozoite surface proteins during and after erythrocyte invasion by Plasmodium falciparum.Cytometric measurement of in vitro inhibition of Plasmodium falciparum field isolates by drugs: a new approach for re-invasion inhibition study.4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle.Gellan sulfate inhibits Plasmodium falciparum growth and invasion of red blood cells in vitro.Defining the Effectiveness of Antimalarial Chemotherapy: Investigation of the Lag in Parasite Clearance Following Drug AdministrationShining new light on ancient drugs: preparation and subcellular localisation of novel fluorescent analogues of Cinchona alkaloids in intraerythrocytic Plasmodium falciparum.High-Content Screening of MMV Pathogen Box for Plasmodium falciparum Digestive Vacuole Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery.Loading antimalarial drugs into noninfected red blood cells: an undesirable roommate for Plasmodium.Identification of Heparin Modifications and Polysaccharide Inhibitors of Plasmodium falciparum Merozoite Invasion That Have Potential for Novel Drug Development.Inhibiting the Plasmodium eIF2α Kinase PK4 Prevents Artemisinin-Induced Latency.Targeted Phenotypic Screening in Plasmodium falciparum and Toxoplasma gondii Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules.Heterologous Expression of a Novel Drug Transporter from the Malaria Parasite Alters Resistance to Quinoline Antimalarials.Imidazolopiperazines Kill both Rings and Dormant Rings in Wild-Type and K13 Artemisinin-Resistant Plasmodium falciparum In Vitro.Superior Pyronaridine Single-Dose Pharmacodynamics Compared to Artesunate, Chloroquine, and Amodiaquine in a Murine Malaria Luciferase ModelCellular dissection of malaria parasite invasion of human erythrocytes using viable Plasmodium knowlesi merozoitesRecent updates in the discovery and development of novel antimalarial drug candidatesA reference document on Permissible Limits for solvents and buffers during in vitro antimalarial screening
P2860
Q26772878-05F51358-0CB9-4655-8159-F2C2B6C14479Q28541891-AD138844-F279-4F47-9E72-36266878454BQ28550911-5869E5E6-D56A-48A6-AA6B-E105FDF8822CQ30658099-F0EF9835-AECB-4A6A-B7CE-2B34CA20D615Q33662226-FDD9169E-99C8-40ED-A152-F03BEC2E5E0AQ33726679-A3D56B1C-0942-4E15-B0D4-77FF4E368383Q34443423-FB369ACB-1070-411A-8E6C-8525817BB582Q35060339-81F91540-F342-4FAE-AF2D-5EEDAC6B1EECQ36051237-B1625539-D0A5-4BB1-BC02-B64D8F069B4CQ36174228-4A515111-E951-4356-97BF-4A6B6354D08FQ36200165-7AE77006-B3F6-4500-A847-AD7EE8F11D6CQ36396055-0D93F59C-225F-4A22-8D3E-CB343A85D794Q36528061-28D53952-6E9D-4742-A76F-FBEC7D59CE31Q36724073-45100313-C93B-4890-B9BC-04B92040492EQ37348404-5DEB68C0-D71F-4707-A51E-B89166EDE44EQ37643916-A00558F0-5DC8-4183-A6A6-BE338B6B6DD6Q37680869-C8D4A592-3F34-4C6E-833E-9FF586FB1942Q37700104-BAAD5D9D-FB23-411F-A88C-B565FBA5E1C7Q37707381-CB72603A-D818-486C-94FA-E87E6E0E126DQ40649128-908DBE3C-BA68-4625-8E2F-306618D46973Q46310228-809CB7DF-58A3-4B76-AAC1-A42D0944D822Q47193275-FFDE65F7-D850-4B7F-BCE4-D06A15C50482Q47917198-70BE1725-B6AB-4CD9-BC73-85C32323F6D7Q48005441-BB6CA1C2-3A41-4F3A-B6A0-759CB6CA951FQ48019234-B67C0756-BCA6-4D65-8350-EA84DF18B884Q48022900-1908DC9F-6C9B-47AA-A2DC-9B517E796085Q48095893-1A78EE16-3C1E-4E1B-B841-E849B600BF23Q52659761-46F65D64-9BE4-499A-B453-9D9DDFA32676Q56339840-42FEE216-6B97-4E15-877C-0BFEBC369343Q56358841-6CB51829-2317-431D-AC23-AF25AF139F61Q56403247-6BFF981B-0B76-45DC-AB1F-9CA92F085462Q57296217-184DEE7A-2D35-48D4-9207-6E6B78917B39
P2860
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
@ast
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
@en
type
label
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
@ast
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
@en
prefLabel
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
@ast
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
@en
P2860
P50
P356
P1476
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
@en
P2093
Christine Langer
Christopher D Goodman
P2860
P304
P356
10.1128/AAC.01881-12
P407
P577
2013-01-14T00:00:00Z